IDEXX Labs (IDXX) Tops Q2 EPS by 30c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- Oil drops as Trump cancels planned strikes against Iran
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Adobe CFO Dan Durn to depart company in June 2026
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
IDEXX Laboratories (IDXX) PT Raised to $700 at Stifel
July 30, 2021 1:36 PM EDTStifel analyst Jonathan D. Block raised the price target on IDEXX Laboratories (NASDAQ: IDXX) to $700.00 (from $600.00) while maintaining a Buy rating following results.
The analyst commented, "IDEXX reported another exceptional quarter with revenue/EPS upside, and management solidly raised 2021 guidance (details below). Importantly,... More
